communityacquir
respiratori
viral
infect
signific
caus
morbid
mortal
patient
undergo
hematopoiet
stem
cell
transplant
hsct
human
parainfluenza
viru
associ
signific
mortal
particularli
lower
respiratori
tract
infect
identifi
larg
transplant
center
incid
infect
high
document
patient
undergo
hsct
hpivinduc
pneumonia
mortal
adult
hsct
patient
infect
viru
predominantli
type
despit
multipl
report
detail
infect
control
implic
morbid
mortal
associ
infect
hsct
recipi
consensu
guidelin
prevent
manag
highli
contagi
respiratori
viru
infect
sever
immunocompromis
host
infect
control
strategi
aim
prevent
viru
acquisit
especi
import
given
hsct
recipi
infect
may
experi
prolong
month
asymptomat
viral
shed
although
ribavirin
shown
activ
hpiv
vitro
vivo
control
clinic
trial
cct
establish
efficaci
human
hpiv
diseas
reason
prevent
viru
acquisit
transmiss
remain
paramount
describ
outbreak
case
infect
hsct
recipi
period
strict
enforc
infect
control
procedur
associ
contain
infect
oregon
health
scienc
univers
portland
larg
referr
center
patient
hematolog
malign
perform
adult
allogen
autolog
hsct
annual
hsct
recipi
treat
inpati
set
admit
differ
transplant
oncolog
ward
staff
visitor
unit
ask
adher
strict
hand
hygien
procedur
enter
ward
patient
treat
outpati
set
seen
clinic
locat
anoth
build
across
street
hospit
layout
opc
consist
larg
wait
room
patient
direct
either
larg
open
infus
center
room
individu
exam
room
studi
intervent
patient
remind
sign
practic
hand
hygien
cover
mouth
cough
mask
respiratori
viral
symptom
howev
organ
ongo
assess
complianc
practic
place
droplet
precaut
practic
outpati
set
investig
usual
limit
patient
obviou
respiratori
tract
infect
contact
isol
usual
limit
patient
colon
vancomycinresist
enterococcu
routin
nasal
swab
wash
respiratori
viral
screen
perform
patient
symptomat
respiratori
ill
implement
intervent
upper
respiratori
tract
infect
urti
defin
presenc
coryza
pharyng
sinus
andor
cough
without
fever
clear
chest
radiograph
lower
respiratori
tract
infect
lrti
defin
presenc
wheez
hypoxia
pneumonia
new
chest
radiograph
opac
low
oxygen
satur
institut
polici
ill
ohsu
employe
patient
contact
illprovid
polici
includ
exclus
duti
includ
contact
patient
day
onset
respiratori
symptom
complianc
polici
strictli
monitor
howev
patient
contact
isol
health
care
provid
famili
member
requir
gown
glove
enter
room
patient
room
droplet
precaut
place
health
care
provid
famili
member
close
contact
patient
requir
wear
mask
hsct
inpati
diagnos
infect
bronchoalveolar
lavag
bal
review
recent
outpati
histori
reveal
multipl
opc
visit
preced
week
base
observ
follow
polici
procedur
empir
undertaken
attempt
assess
preval
hsct
opc
prevent
potenti
spread
diseas
adult
patient
bone
marrow
transplant
bmt
center
earli
august
septemb
sign
symptom
urti
lrti
outpati
set
underw
detail
clinic
evalu
sampl
acquir
urt
lrt
wash
patient
lrti
new
pulmonari
abnorm
comput
tomographi
scan
underw
bal
opc
patient
famili
member
ask
wash
hand
screen
acut
respiratori
ill
entri
opc
see
symptomat
patient
immedi
mask
place
privat
room
contact
droplet
precaut
respiratori
viral
screen
sampl
obtain
symptomat
famili
member
ask
remain
area
wait
room
separ
patient
detail
guidelin
script
phone
clinic
triag
creat
use
staff
question
patient
whether
present
phone
clinic
respiratori
transmiss
inform
sign
request
patient
famili
member
friend
respiratori
symptom
practic
hand
hygien
mask
immedi
post
outsid
clinic
door
insid
outpati
unit
hsct
inpati
unit
staff
involv
patient
care
outpati
inpati
set
question
recent
urti
lrti
symptom
sign
adher
institut
illprovid
polici
made
mandatori
sign
urti
lrti
elicit
visit
symptomat
famili
member
prohibit
decis
whether
admit
patient
treatment
decis
made
hsct
provid
team
consult
infecti
diseas
servic
patient
document
ask
adher
strict
hand
hygien
polici
wear
mask
month
activ
infect
opc
visit
place
privat
room
durat
inpati
set
addit
forego
precaut
follow
procedur
institut
hsct
inpati
respiratori
ill
isol
screen
respiratori
viral
sampl
obtain
nasopharyng
wash
obtain
hsct
recipi
urti
symptom
bal
lrti
submit
viral
test
shell
vial
cultur
perform
specimen
sent
viral
test
shell
vial
cultur
screen
hour
use
pool
monoclon
antibodi
mab
panel
respiratori
virus
diagnost
hybrid
athen
oh
includ
adenoviru
influenza
b
respiratori
syncyti
viru
rsv
posit
specimen
stain
individu
mab
identifi
viru
neg
hour
shell
vial
cultur
screen
hour
isol
obtain
outbreak
period
sent
blind
center
diseas
control
prevent
cdc
molecular
type
reversetranscript
polymeras
chain
reaction
rtpcr
sequenc
nucleotid
variabl
region
hemagglutininneuraminidas
hn
gene
perform
describ
previous
select
isol
resequenc
new
rna
extract
confirm
result
nucleotid
align
compil
use
pileup
program
wisconsin
packag
version
unix
accelri
san
diego
ca
phylogenet
analysi
perform
maximum
likelihood
use
paup
version
sinauer
associ
sunderland
patient
lrti
secondari
treat
ribavirin
ribavirin
administ
endotrach
tube
hour
day
continu
aerosol
iv
dosag
aerosol
ribavirin
gday
day
iv
ribavirin
initi
load
dose
mgkg
bodi
weight
follow
mgkg
everi
hour
day
mgkg
time
day
addit
day
juli
august
hsct
recipi
diagnos
infect
case
inpati
outpati
diagnosi
tabl
sumar
patient
characterist
molecular
type
hn
gene
avail
isol
identifi
least
genet
distinct
group
figur
one
group
contain
singl
isol
obtain
first
recogn
case
patient
transfer
inpati
servic
outsid
facil
mile
away
second
group
contain
isol
ident
sequenc
patient
third
group
contain
isol
ident
sequenc
patient
uniqu
sequenc
differ
other
nucleotid
substitut
isol
patient
unavail
patient
diagnos
outsid
facil
transfer
ohsu
late
cours
first
case
infect
diagnos
june
patient
transfer
outsid
hospit
respiratori
distress
bal
perform
next
day
test
posit
second
case
identifi
month
later
juli
inpati
hsct
unit
august
august
case
identifi
enhanc
infect
control
polici
enforc
start
august
clinic
visit
chart
inpati
hospit
room
assign
review
inpati
nosocomi
transmiss
suspect
major
case
base
lack
inpati
physic
proxim
preval
diagnosi
outpati
set
admiss
hospit
identif
establish
respiratori
diseas
case
whinch
hpiv
molecular
type
perform
patient
least
one
potenti
share
exposur
common
clinic
day
preced
month
anoth
infect
patient
share
multipl
clinic
visit
review
context
molecular
analysi
determin
patient
group
viru
common
clinic
day
other
group
june
juli
patient
group
virus
seen
juli
seen
august
questionnair
given
clinic
staff
elicit
person
acknowledg
respiratori
sign
symptom
work
outbreak
period
howev
multipl
staff
member
note
intervent
period
sever
unmask
symptomat
patient
famili
member
care
open
care
area
opc
major
infect
control
intervent
introduc
august
august
epidem
curv
reveal
infect
frequenc
peak
august
august
figur
overal
mortal
patient
diagnos
patient
die
sign
lrti
treat
inhal
ribavirin
spectrum
diseas
hsct
recipi
rang
uncompl
urti
character
rhinorrhea
pharyng
coryza
sever
lrti
may
lead
pneumonia
respiratori
failur
death
epidemiolog
infect
hsct
differ
associ
latent
endogen
viral
infect
cytomegaloviru
cmv
infect
patient
serolog
statu
degre
immunosuppress
play
major
role
diseas
occurr
retrospect
analysi
case
shown
correl
infect
type
transplant
degre
immunosuppress
howev
major
case
still
link
primarili
patient
exposur
viru
factor
like
contribut
individu
patient
suscept
viral
transmiss
occur
direct
inocul
contagi
secret
hand
larg
particl
aerosol
eye
nose
rare
mouth
prolong
surviv
skin
cloth
object
emphas
import
fomit
spread
nosocomi
viru
critic
import
handwash
control
infect
transmiss
immunocompet
adult
infect
rare
caus
signific
morbid
mortal
howev
hsct
recipi
establish
pneumonia
mortal
rate
high
current
establish
treatment
regimen
shown
reduc
diseas
highli
transmiss
associ
signific
morbid
prevent
exposur
vulner
popul
may
critic
intervent
pursu
aggress
infect
control
measur
play
key
role
prevent
infect
sequela
compromis
host
may
complic
fact
viral
shed
may
either
asymptomat
prolong
although
guidelin
regard
prevent
rsv
influenza
practic
concern
base
data
extrapol
studi
consensu
guidelin
prevent
manag
strategi
infect
sever
immunocompromis
patient
lack
cluster
patient
laboratoryconfirm
infect
geograph
proxim
molecular
type
viru
suggest
mani
patient
viru
acquisit
like
nosocomi
took
place
share
open
outpati
infus
area
clinic
evalu
clinic
environ
questionnair
staff
support
plausibl
find
outbreak
number
patient
famili
member
urti
present
common
area
opc
infus
center
close
proxim
patient
without
isol
precaut
activ
infect
control
intervent
orient
toward
strict
limit
patienttopati
contact
associ
control
viral
spread
rel
short
period
although
epidem
curv
suggest
control
intervent
could
argu
decreas
incid
case
repres
natur
progress
outcom
diseas
demonstr
cdc
nation
respiratori
enter
viru
surveil
system
nrevss
region
surveil
data
howev
studi
fred
hutchinson
cancer
research
center
shown
unlik
commun
activ
outbreak
immunocompromis
host
typic
follow
season
pattern
nosocomi
spread
multiseason
well
rapid
prolong
thu
seem
like
control
measur
introduc
outpati
hsct
clinic
play
role
curtail
epidem
outcom
patient
nonrandom
studi
noteworthi
detail
tabl
patient
urti
treat
recov
eight
patient
present
establish
lrti
treat
ribavirin
die
treat
ribavirin
recov
patient
lrti
treat
ribavirin
die
recov
final
patient
treat
ribavirin
earli
cours
probabl
lrti
recov
although
control
data
suggest
benefit
aerosol
ribavirin
treatment
patient
establish
lrti
accentu
critic
need
intervent
prevent
transmiss
better
therapeut
modal
welldesign
clinic
trial
explor
complic
area
would
use
help
guid
intervent
like
unfeas
rel
infrequ
event
thu
conclud
develop
adher
strict
isol
polici
patient
famili
member
care
provid
activ
respiratori
infect
may
best
avail
intervent
summari
patient
infect
associ
signific
morbid
mortal
identifi
hsct
popul
academ
medic
institut
sever
month
base
genet
related
well
demograph
exposur
histori
major
case
acquisit
like
occur
hsct
opc
prompt
attent
focu
infect
control
intervent
associ
rapid
decreas
number
incid
case
polici
procedur
address
approach
patient
respiratori
viral
ill
hsct
opc
popul
formul
reinforc
clinic
staff
help
prevent
spread
infect
given
possibl
asymptomat
prolong
viral
shed
pauciti
document
effect
treatment
strategi
high
mortal
emerg
newli
identifi
viral
respiratori
pathogen
eg
bocaviru
coronavirus
infect
prevent
polici
emphas
high
vigil
strict
respiratori
etiquett
throughout
year
larger
prospect
control
studi
would
use
better
clarifi
role
infect
control
practic
infect
hsct
recipi
